Perspectives on anti-CD47 antibody treatment for experimental cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 27, 2013, Pages 10886-10887

  Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CD47 MONOCLONAL ANTIBODY; CYTOSKELETON PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXPERIMENTAL NEOPLASM; GRANULOCYTE; IMMUNE RESPONSE; INHIBITION KINETICS; INNATE IMMUNITY; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NONHUMAN; NOTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD47; COLONIC NEOPLASMS; HUMANS; MACROPHAGES; T-LYMPHOCYTES;

EID: 84879711611     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308463110     Document Type: Note

References (19)

1. Tseng D, et al. (2013) Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci USA 110:11103-11108.
2. Chao MP, Weissman IL, Majeti R (2012) The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 24(2):225-232.
3. Kim D, et al. (2012) Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia 26(12):2538-2545.
4. Majeti R, et al. (2009) CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138(2):286-299.
5. Oldenborg PA (2013) CD47: A cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease. ISRN Hematol 2013:614619.
6. Campbell IG, Freemont PS, Foulkes W, Trowsdale J (1992) An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 52(19):5416-5420.
7. Brown E, Hooper L, Ho T, Gresham H (1990) Integrin-associated protein: A 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111(6 Pt 1):2785-2794. (Pubitemid 120014559)
8. Oldenborg PA, et al. (2000) Role of CD47 as a marker of self on red blood cells. Science 288(5473):2051-2054.
9. Kärre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319(6055):675-678. (Pubitemid 16119452)
10. Jonsson AH, Yokoyama WM (2009) Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 101:27-79.
11. Willingham SB, et al. (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109(17):6662-6667.
12. Chao MP, et al. (2010) Calreticulin is the dominant prophagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2(63):63ra94.
13. Obeid M, et al. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13(1):54-61. (Pubitemid 46067386)
14. Gardai SJ, et al. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123(2):321-334. (Pubitemid 41457220)
15. Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC (2010) Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol 185(6):3426-3435.
16. Unanue ER (1981) The regulatory role of macrophages in antigenic stimulation. Part Two: Symbiotic relationship between lymphocytes and macrophages. Adv Immunol 31:1-136.
17. Gray EE, Cyster JG (2012) Lymph node macrophages. J Innate Immun 4(5-6):424-436.
18. Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480(7378):480-489.
19. Matsushita H, et al. (2012) Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482(7385):400-404.